PJ, February 2017, Vol 298, No 7898

How RPS members can run for election to the Scottish Pharmacy Board in 2017

The scheme for the 2017 election provides for four places on the Scottish Pharmacy Board for members or Fellows who work or live wholly or mainly in Scotland. The eligibility criteria are set out below. Nominations for candidates in the Scottish Pharmacy Board election must be made until 28 Fe…

How RPS members can run for election to the English Pharmacy Board in 2017

The scheme for the 2017 election provides for five places on the English Pharmacy Board for members or Fellows who work or live wholly or mainly in England, the Channel Islands or the Isle of Man. The eligibility criteria are set out below. Please note that, as of 2016, places on the English P…

How RPS members can run for election to the Welsh Pharmacy Board in 2017

The scheme for the 2017 election provides for four places on the Welsh Pharmacy Board for members or Fellows who work or live wholly or mainly in Wales. The four places are to be allocated as follows: (a) one place for a member whose substantive practice is in the community practice sect…

Your RPS needs you

Show your passion and dedication to pharmacy by putting yourself forward for this year’s RPS national pharmacy board elections.…

Atopic dermatitis: dupilumab and crisaborole could herald a new era in treatment

Atopic dermatitis can have a devastating effect on quality of life, but there have been no major changes to the way it has been treated for over 15 years. Now, two new therapies — dupilumab, a biologic for severe disease, and crisaborole, a topical small molecule drug for milder disease &mdash…

Atopic dermatitis: emerging and current treatments

Atopic dermatitis affects up to 30% of children and 10% of adults, and is common in both developed and developing countries. Two new medicines on the brink of entering the market — dupilumab, a biologic for severe disease, and crisaborole, a topical small molecule drug for milder disease &mdas…

Q&A: Farewell to RPS chief executive, Helen Gordon

After seven years in the pharmacy world, Helen Gordon is departing as chief executive of the Royal Pharmaceutical Society to enter pastures new at the Royal Society of Medicine. Here, she talks to Julia Robinson about her proudest moments and what advice she would give to her successor. …

Recommendations made in Murray’s review for community pharmacy will not be simple to implement

Practical challenges, including building closer relationships with GPs, will need to be overcome if the recommendations in the Murray review on community pharmacy are to be implemented successfully.…

The Murray review: moving in the right direction

On 20 December 2016, six days after the long-awaited report by the King’s Fund’s Richard Murray on the provision of clinical services in community pharmacy was published, health minister David Mowat described the review as “an essential road map that sets out how we are going to mo…

Preconception care: genetic and pre-existing conditions

Pharmacists and healthcare professionals can provide appropriate and comprehensive preconception care by identifying couples who are at risk of having a baby with a genetic or chromosomal malformation and can empower the couple by giving them enough knowledge to make informed decisions.…